About

About Centre for Translational Stem Cell Biology Centre for Translational Stem Cell Biology (CTSCB) provides Hong Kong with an opportunity to excel in scientific and medical research. A team of top-notch scientists and clinicians from the University of Hong Kong and the University of Cambridge collaborates to elevate stem cell technology to new heights. By leveraging a pioneering patented technology, Expanded Potential Stem Cells (EPSCs), CTSCB is dedicated to advancing fundamental research and translating discoveries into regenerative medicine, organ transplantation and genomic medicine for the benefit of people worldwide. CTSCB primarily focuses on producing mature and functional cells for regenerative medicine with the patented technology, enabling in-depth study of immune disease mechanism, and expediting the development of antiviral, anti-ageing natural products and antibody drugs. Our vision is to translate medical discoveries and homegrown technologies into applications that not only serve medical and biotechnological purposes but also extend to the agricultural sector, fostering the growth of innovation and technology. About Centre for Translational Stem Cell Biology Centre for Translational Stem Cell Biology (CTSCB) provides Hong Kong with an opportunity to excel in scientific and medical research. A team of top-notch scientists and clinicians from the University of Hong Kong and the University of Cambridge collaborates to elevate stem cell technology to new heights. By leveraging a pioneering patented technology, Expanded Potential Stem Cells (EPSCs), CTSCB is dedicated to advancing fundamental research and translating discoveries into regenerative medicine, organ transplantation and genomic medicine for the benefit of people worldwide. CTSCB primarily focuses on producing mature and functional cells for regenerative medicine with the patented technology, enabling in-depth study of immune disease mechanism, and expediting the development of antiviral, anti-ageing natural products and antibody drugs. Our vision is to translate medical discoveries and homegrown technologies into applications that not only serve medical and biotechnological purposes but also extend to the agricultural sector, fostering the growth of innovation and technology. Imagine a future where healthcare is transformed by cutting-edge stem cell technology. Centre for Translational Stem Cell Biology (CTSCB), a collaboration between the University of Hong Kong and the University of Cambridge, supported by the Innovation and Technology Commission, is at the forefront of making this vision a reality. Leveraging patented Expanded Potential Stem Cell (EPSC) technology, we can create any cell type, both embryonic and extra-embryonic, offering immense potential for regenerative medicine and therapeutic applications. Our research focuses on intelligent drug screening, precision medicine and cell-based therapies. We develop next-generation stem cell technology that improves patient outcomes and enhances quality of life. Our drug screening platforms support pharmaceutical and health supplement companies in streamlining their development processes using multicellular organoid systems and personalized disease modelling. We also explore health and cosmetic products derived from EPSC technology, with interests in product co-development to address various health issues. By attracting top global talent and fostering innovation, CTSCB is well-positioned to enhance therapeutic applications and promote longevity. Through our innovative research and commitment to excellence, CTSCB aims to lead the way in revolutionary healthcare solutions for generations to come.